Leadership in health care private equity since 1986

"Without their support and guidance, BioRexis would have never even gotten off the ground. It was in every sense an honor and pleasure to be their partners in BioRexis. "

 

— David R. King, CEO

 

Pharma & Biotech

We have invested in a range of pharmaceutical companies across our funds. A major area of success has been investments into commercial stage companies seeking to establish a leading franchise position for their product(s). We have helped a number of companies in this capacity, including Adams Respiratory (developers of Mucinex), BioRexis, Synageva BioPharma, and others.

INVESTMENT CASE STUDY: Pharma & Biotech Investment

Biorexis_Pic_copy2_20120802104648.png

BioRexis — Developer of novel, long-lasting versions of known biopharmaceuticals using proprietary protein engineering technology. Products can also be produced in highly efficient, yeast-based manufacturing systems.